Reduced Leaflet Motion in Bioprosthetic Aortic Valves — The FDA Perspective
Reduced Leaflet Motion in Bioprosthetic Aortic Valves — The FDA Perspective
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The incidence and mechanism of reduced leaflet motion in bioprosthetic aortic valves and the accompanying risks cannot yet be fully characterized. Whether it is clinically meaningful or merely an advanced-imaging phenomenon demands additional investigation.
Bioprosthetic aortic valves play a critical role in improving the health and quality of l...
Alternative Titles
Full title
Reduced Leaflet Motion in Bioprosthetic Aortic Valves — The FDA Perspective
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1735333333
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1735333333
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMp1512264
